Credits Earned (2024) Crédits obtenus

Redeem Prepaid Membership

Tools for Practice Outils pour la pratique


#40 Topical NSAIDs: Do they top Placebo or Oral NSAIDs?


CLINICAL QUESTION
QUESTION CLINIQUE
Are topical non-steroidal anti-inflammatories (NSAIDs) effective in reducing pain in acute and chronic (including osteoarthritis) musculoskeletal pain?


BOTTOM LINE
RÉSULTAT FINAL
In acute and chronic (like osteoarthritis) musculoskeletal pain, topical NSAIDs are superior to placebo and equivalent to oral NSAIDs. Topical NSAIDs adverse event rates are not statistically greater than placebo.



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
Acute musculoskeletal pain: Systematic review of 47 randomized controlled trials (RCTs) with 5,512 patients (within 24-48 hours onset).1 
  • Clinical success (defined as 50% pain reduction, good pain relief, or equivalent): Statistically significantly greater with topical NSAID vs. placebo, relative benefit 1.5 [Confidence Interval (CI) 1.4-1.6] 
    • Topical NSAID 65% vs. placebo 43%, Number Needed to Treat (NNT)=5.  
  • Topical diclofenac, ibuprofen, ketoprofen, and piroxicam were all effective. 
  • Adverse events and withdrawals were not different. 
  • Benefit decreased over time: 6-8 days NNT=4 and 9-14 days NNT=10. 
    • This may be due to recovery over time in the placebo arm.   
Chronic musculoskeletal pain (including osteoarthritis): Four systematic reviews comparing topical NSAIDs to placebo.2-5  
  • Short-term (two weeks) effects: Consistent statistically significant improvement.2,3 Example, relative benefit 1.9 (CI 1.7-2.2), NNT=5 for improved pain over placebo.3   
  • Long-term (=12 weeks) effects: Statistically significant pain reduction vs. placebo, NNT=11.5 
  • Comparing topical to oral NSAIDs: Pain control is similar (relative risk 1.1, CI 0.9-1.3).3,5  Overall withdrawals for adverse effects is also similar.5  
Context:  
  • Other meta-analyses6,7 support topical NSAIDs in acute musculoskeletal pain or single joint osteoarthritis.  
    • Present evidence does not support topical NSAIDs in back pain, neuropathic conditions or widespread pain.7  
  • UK osteoarthritis guidelines place topical NSAIDs (or acetaminophen) as first line pharmacotherapy for knee and/or hand osteoarthritis.8 
    • Intra-articular NSAID levels are therapeutic with topical or oral but circulation levels of topical NSAIDs are 15% of oral NSAIDs.8 
  • Recommending specific formulations is challenged by the lack of trials comparing different formulations (types of gels/creams) on clinical outcomes. 


Latest Tools for Practice
Derniers outils pour la pratique

#374 Vitamin D and Fracture Prevention: Not what it’s cracked up to be?

Does vitamin D prevent fragility fractures?
Read Lire 0.25 credits available Crédits disponibles

#373 Strategies for initiating insulin in type 2 diabetes

What is the optimal initial insulin for patients with type 2 diabetes?
Read Lire 0.25 credits available Crédits disponibles

#372 Mission Slimpossible Part 2: Oral GLP-1 agonists for weight loss

Are oral GLP-1 agonists effective for weight loss?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


1. Massey T, Derry S, Moore AR, et al. Cochrane Database System Rev. 2014; 6:CD007402.

2. Lin J, Zhang W, Jones A, et al. BMJ. 2004; 329:324.

3. Mason L, Moore RA, Edwards JE, et al. BMC Musculoskeletal Disorders. 2004; 5:28.

4. Biswal S, Medhi B, Pandhi P. J Rheumatol. 2006; 33:1841-4.

5. Derry S, Moore RA, Rabbie R. Cochrane Database System Rev. 2012; 9:CD007400.

6. Bandolier. Topical NSAIDs. 2003 April. Available at: http://www.medicine.ox.ac.uk/bandolier/band110/b110-6.html. Accessed February 12, 2015.

7. Haroutiunian S, Drennan DA, Lipman AG. Pain Medicine. 2010; 11:535-49.

8. National Institute for Health and Care Excellence. Osteoarthritis Care and Management in Adults (clinical guidelines CG177). February 2014. Available at: http://www.nice.org.uk/guidance/cg177/evidence/cg177-osteoarthritis-full-guideline3. Accessed February 12, 2015.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.

Most recent review: 10/02/2015

By: Adrienne J Lindblad BSP ACPR PharmD

Comments:

Evidence Updated: Systematic review added; Bottom Line: Unchanged.

Learning at a glance
Yearly credits
Acquired ()
Your content by topic
Cardiology Dermatology Emergency
My Bookmarks